The heart in Ras-MAPK pathway disorders

Monographs in Human Genetics

Volumn 17, Issue , 2009, Pages 109-118

  Digilio, M C ^a   Marino, B ^b   Sarkozy, A ^c   Versacci, P ^b   Dallapiccola, B ^c  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84864576678     PISSN: 00770876     EISSN: 16623835     Source Type: Book Series    
DOI: 10.1159/000164847     Document Type: Article

References (84)

1. Noonan JA, Ehmke DA: Associated noncardiac malformations in children with congenital heart disease. J Pediatr 1963;63:468-470.
2. Caralis DG, Char F, Graber JD, Voigt GC: Delineation of multiple cardiac anomalies associated with the Noonan syndrome in an adult and review of the literature. Johns Hopkins Med J 1974;134:346-355.
3. Noonan JA: Hypertelorism with Turner phenotype. A new syndrome with associated congenital heart disease. Am J Dis Child 1968;116:373-380.
4. Siggers DC, Polani PE: Congenital heart disease in male and female subjects with somatic features of Turner's syndrome and normal sex chromosomes (Ullrich's and related syndromes). Br Heart J 1972;34:41-46.
5. Nora JJ, Nora AH, Sinha AK, Spangler RD, Lubs HA: The Ullrich-Noonan syndrome (Turner phenotype). Am J Dis Child 1974;127:48-55.
6. Pearl W: Cardiovascular anomalies in Noonan's syndrome. Chest 1977;71:677-679. (Pubitemid 8111583)
7. Van der Hauwaert LG, Fryns JP, Dumoulin M, Logghe N: Cardiovascular malformations in Turner's and Noonan's syndrome. Br Heart J 1978;40:500-509. (Pubitemid 8341082)
8. Engle MA, Ehlers KH: Cardiovascular malformations in the syndrome of Turner phenotype with normal karyotype. BD:OAS 1972;8:104-109.
9. Pernot C, Hoeffel JC, Worms AM, Ravault MC, Contet-Audonneau N: Les sténoses pulmonaires atypiques au cours de certains syndromes polymalformatifs: Fréquence de la myocardiopathie hypertrophique associée. Arch Mal Coeur 1977;70:391-398. (Pubitemid 8092916)
10. Hoeffel JC, Ravault MC, Worms AM, Pernot C: Atypical pulmonary stenosis: Radiological features. Am Heart J 1979;98:315-320. (Pubitemid 10217710)
11. Noonan JA: Association of congenital heart disease with syndromes or other defects. Pediatr Clin North Am 1978;25:797-816. (Pubitemid 9018825)
12. Tartaglia M, Gelb BD: Noonan syndrome and related disorders: Genetics and pathogenesis. Ann Rev Genomics Hum Genet 2005;6:45-68. (Pubitemid 41397075)
13. Denayer E, Legius E: What's new in the neuro-cardio-facial-cutaneous syndromes? Eur J Pediatr 2007;166:1091-1098. (Pubitemid 47476634)
14. Sarkozy A, Conti E, Seripa D, Digilio MC, Grifone N, et al: Correlation between PTPN11 gene mutations and congenital heart defects in Noonan and LEOPARD syndromes. J Med Genet 2003;40:704-708. (Pubitemid 37100705)
15. Burch M, Sharland M, Shinebourne E, Smith G, Patton M, McKenna W: Cardiologic abnormalities in Noonan syndrome: phenotypic diagnosis and echocardiographic assessment in 118 patients. J Am Coll Cardiol 1993;22:1189-1192. (Pubitemid 23285775)
16. Marino B, Digilio MC, Toscano A, Giannotti A, Dallapiccola B: Congenital heart diseases in children with Noonan syndrome: an expanded cardiac spectrum with high prevalence of atrioventricular canal. J Pediatr 1999;135:703-706. (Pubitemid 30180418)
17. Ferencz C, Loffredo CA, Correa-Villasenor A, Wilson PD: Genetic and environmental risk factors of major cardiovascular malformations. The Baltimore-Washington Infant Study 1981-1989 (Futura Publishing Company Inc., Armonk, New York 1997).
18. Narayanswami S, Kitchiner D, Smith A: Spectrum of valvar abnormalities in Noonan's syndrome. A pathologic study. Cardiol Young 1994;4:62-66.
19. Koretzki ED, Moller JH, Korus ME, Schwartz CJ, Eduards JE: Congenital pulmonary stenosis resulting from dysplasia of the valve. Circulation 1969;40:43-45.
20. Neill CA: Congenital cardiac malformations and syndromes, in Pierpont MEM, Moller JH (eds): Genetics of Cardiovascular Disease, pp 95-112 (Martinus-Nijoff Publishing, Boston, 1987).
21. Sarkozy A, Conti E, Esposito G, Pizzuti A, Dallapiccola B, et al: Nonsyndromic pulmonary valve stenosis and the PTPN11 gene. Am J Med Genet A 2003;116:389-390. (Pubitemid 37063597)
22. Siwik ES, Zahka KG, Wiesner GL, Limwongse C: Cardiac disease in Costello syndrome. Pediatrics 1998;101:706-709. (Pubitemid 28180162)
23. Tomita H, Fuse S, Ikeda K, Matsuda K, Chiba S: An infant with Costello syndrome complicated by fatal hypertrophic obstructive cardiomyopathy. Acta Paediatr Jap 1998;40:608-611. (Pubitemid 29001941)
24. Lin AE, Grossfeld PD, Hamilton RM, Smoot L, Gripp KW, et al: Further delineation of cardiac abnormalities in Costello syndrome. Am J Med Genet 2002;111:115-129. (Pubitemid 34809491)
25. Limongelli G, Pacileo G, Marino B, Digilio MC, Sarkozy A, et al: Prevalence and clinical significance of cardiovascular abnormalities in patients with the LEOPARD syndrome. Am J Cardiol 2007;100:736-741. (Pubitemid 47223154)
26. Marino B, Gagliardi MG, Digilio MC, Polletta B, Grazioli S, et al: Noonan syndrome: structural abnormalities of the mitral valve causing subaortic obstruction. Eur J Pediatr 1995;154:949-952.
27. Digilio MC, Sarkozy A, Pacileo G, Limongelli G, Marino B, Dallapiccola B: PTPN11 gene mutations: linking the Gln510Glu mutation to the 'LEOPARD syndrome phenotype'. Eur J Pediatr 2006;165:803-805. (Pubitemid 44440520)
28. Colan SD, Lipshultz SE, Lowe AM, Sleeper LA, Messere J, et al: Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children. Finding from the pediatric cardiomyopathy registry. Circulation 2007;115:776-781.
29. Nora JJ, Lortscher RH, Spangler RD: Echocardiographic studies of left ventricular disease in Ullrich-Noonan syndrome. Am J Dis Child 1975;129:1417-1420.
30. Starr A, Hovaguimian H: Surgical repair of subaortic stenosis in atrioventricular canal defects. J Thorac Cardiovasc Surg 1994;108:373-376. (Pubitemid 24258677)
31. Feit LR, Hansen K, Oyer CE, Werner JC: Unusual combination of congenital heart defects in an infant with Noonan syndrome. Pediatr Cardiol 1995;16:95-99.
32. Digilio MC, Marino B, Toscano A, Giannotti A, Dallapiccola B: Atrioventricular canal defect without Down syndrome: a heterogeneous malformation. Am J Med Genet 1999;85:140-146. (Pubitemid 29288339)
33. Hirsch HD, Gelband H, Garcia O, Gottlieb S, Tamer DM: Rapidly progressive obstructive cardiomyopathy in infants with Noonan's syndrome. Reports of two cases. Circulation 1975;52:1161-1165.
34. Klues HG, Roberts WC, Maron BJ: Anomalous insertion of papillary muscle directly into anterior mitral leaflet in hypertrophic cardiomyopathy. Significance in producing left ventricular outflow obstruction. Circulation 1991;84:1188-1197.
35. Klues HG, Maron BJ, Dollar AL, Roberts WC: Diversity of structural mitral valve alterations in hypertrophic cardiomyopathy. Circulation 1992;85:1651-1660.
36. Clark EB: Mechanisms in the pathogenesis of congenital heart defects; in Pierpont ME, Moller JM (eds): The Genetics of Cardiovascular Disease, pp 3-11 (Martinus-Nijoff, Boston, 1986).
37. Tartaglia M, Pennacchio LA, Zhao C, Yadav KK, Fodale V, et al: Gain-offunction SOS1 mutations cause a distinctive form of Noonan syndrome. Nat Genet 2007;39:75-79. (Pubitemid 46026504)
38. Sznajer Y, Keren B, Baumann C, Pereira S, Alberti C, et al: The spectrum of cardiac anomalies in Noonan syndrome as a result of mutations in the PTPN11 gene. Pediatrics 2007;119:1325-1331.
39. Hasegawa T, Ogata T, Hasegawa Y, Honda M, Nagai T, et al: Coarctation of the aorta and renal hypoplasia in a boy with Turner-Noonan surface anomalies and a 46, XY karyotype: A clinical model for the possible impairment of a putative lymphogenic gene (s) for Turner somatic stigmata. Hum Genet 1996;97:564-567.
40. Digilio MC, Marino B, Picchio F, Prandstraller D, Toscano A, Giannotti A, Dallapiccola B: Noonan syndrome and aortic coarctation. Am J Med Genet 1998;80:160-162. (Pubitemid 28485697)
41. Lemire EG: Noonan syndrome or new autosomal dominant condition with coarctation of the aorta, hypertrophic cardiomyopathy, and minor anomalies. Am J Med Genet 2002;113:286-290. (Pubitemid 35303844)
42. Digilio MC, Marino B, Giannotti A, Dallapiccola B: Exclusion of 22q11 deletion in Noonan syndrome with tetralogy of Fallot. Am J Med Genet 1996;62:413-414.
43. Shachter N, Perloff JK, Mulder DG: Aortic dissection in Noonan's syndrome (46 XY Turner). Am J Cardiol 1984;54:464-465. (Pubitemid 14055791)
44. Lin AE, Garver KL, Allanson J: Aorticroot dilatation in Noonan's syndrome. N Engl J Med 1987;317:1668-1669.
45. Power PD, Lewin MB, Hannibal MC, Glass IA: Aortic root dilatation is a rare complication of Noonan syndrome. Pediatr Cardiol 2006;27:478-480. (Pubitemid 44222403)
46. Allanson JE: Noonan syndrome. J Med Genet 1987;24:9-13. (Pubitemid 17228867)
47. Patton MA: Noonan syndrome: A review. Growth Genet Horm 1994;33:1-3.
48. Sharland M, Burch M, McKenna WM, Patton MA: A clinical study of Noonan syndrome. Arch Dis Child 1992;67:178-183.
49. Tartaglia M, Kalidas K, Shaw A, Song X, Musat DL, et al: PTPN11 mutations in Noonan syndrome: Molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity. Am J Hum Genet 2002;70:1555-1563. (Pubitemid 34533902)
50. Sarkozy A, Conti E, Digilio MC, Marino B, Morini E, et al: Clinical and molecular analysis of 30 patients with multiple lentigines LEOPARD syndrome. J Med Genet 2004;41:e68.
51. Zenker M, Buheitel G, Rauch R, Koenig R, Bosse K, et al: Genotype-phenotype correlations in Noonan syndrome. J Pediatr 2004;144:368-374. (Pubitemid 38333896)
52. Jongmans M, Sistermans EA, Rikken A, Nillessen WM, Tamminga R, et al: Genotypic and phenotypic characterization of Noonan syndrome: New data and review of the literature. Am J Med Genet A 2005;134:165-170. (Pubitemid 40446212)
53. Musante L, Kehl HG, Majewski F, Meinecke P, Schweiger S, et al: Spectrum of mutations in PTPN11 and genotypephenotype correlation in 96 patients with Noonan syndrome and five patients with cardio-facio-cutaneous syndrome. Eur J Hum Genet 2002;11:201-206.
54. Kamisago M, Hirayama-Yamad K, Kato T, Imamura S, Joo K, et al: Missense mutations in the PTPN11 as a cause of cardiac defects associated with Noonan syndrome; in Artman M, Benson DW, Srivastava D, Nakazawa M (eds): Cardiovascular Development and Congenital Malformations. Molecular and Genetic Mechanisms, pp 273-276 (Blackwell Futura Publishing, Malden, Massachusetts, 2005).
55. Pandit B, Sarkozy A, Pennacchio LA, Carta C, Oishi K, et al: Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy. Nat Genet 2007;39:1007-1012. (Pubitemid 47185177)
56. Razzaque MA, Nishizawa T, Komoike Y, Yagi H, Furutani M, et al: Germline gain-of-function mutations in RAF1 cause Noonan syndrome. Nat Genet 2007;39:1013-1017. (Pubitemid 47185179)
57. Digilio MC, Conti E, Sarkozy A, Mingarelli R, Dottorini T, et al: Grouping of Multiple Lentigines/LEOPARD and Noonan syndrome on the PTPN11 gene. Am J Hum Genet 2002;71:389-394. (Pubitemid 34800254)
58. Digilio MC, Sarkozy A, De Zorzi A, Pacileo G, Limongelli G, et al: LEOPARD syndrome: Clinical diagnosis in the first year of life. Am J Med Genet A 2006;140:740-746.
59. Chen B, Bronson RT, Klaman RD, Hampton TG, Wang J-F, et al: Mice mutant for Egfr and Shp2 have defective cardiac semilunar valvulogenesis. Nat Genet 2000;24:296-299. (Pubitemid 30132202)
60. Marino B, Digilio MC: Congenital heart disease and genetic syndromes: specific correlation between cardiac phenotype and genotype. Cardiovasc Pathol 2000;9:303-315. (Pubitemid 32012558)
61. Krenz M, Yutzey KE, Robbins J: Noonan syndrome mutation Q79R in Shp2 increases proliferation of valve primordia mesenchymal cells via extracellular signal regulated kinase 1/2 signaling. Circ Res 2005;97:813-820. (Pubitemid 41447132)
62. Roberts AE, Araki T, Swanson KD, Montgomery KT, Schiripo TA, et al: Germline gain-of-function mutations in SOS1 cause Noonan syndrome. Nat Genet 2007;39:70-74. (Pubitemid 46026503)
63. Zenker M, Horn D, Wieczorek D, Allanson J, Pauli S, et al: SOS1 is the second most common Noonan gene but plays no major role in cardio-facio-cutaneous syndrome. J Med Genet 2007;44:651-656. (Pubitemid 47584760)
64. Schubbert S, Zenker M, Rowe SL, Boll S, Klein C, et al: Germline KRAS mutations cause Noonan syndrome. Nat Genet 2006;38:331-336.
65. Carta C, Pantaleoni F, Bocchinfuso G, Stella L, Vasta I, et al: Germline missense mutations affecting KRAS isoform B are associated with a severe Noonan syndrome phenotype. Am J Hum Genet 2006;79:129-135. (Pubitemid 43927383)
66. Zenker M, Lehmann K, Schulz AL, Barth H, Hansmann D, et al: Expansion of the genotypic and phenotypic spectrum in patients with KRAS germline mutations. J Med Genet 2007;44:131-135.
67. Legius E, Schrander-Stumpel C, Schollen E, Pulles-Heintzberger C, Gewillig M, Fryns JP: PTPN11 mutations in LEOPARD syndrome. J Med Genet 2002;39:571-574. (Pubitemid 34864560)
68. Keren B, Hadchouel A, Saba S, Sznajer Y, Bonneau D, et al, for the French Collaborative Noonan Study Group: PTPN11 mutations in patients with LEOPARD syndrome: a French multicentric experience. J Med Genet 2004;41:e117.
69. Yoshida R, Nagai T, Hasegawa T, Kinoshita E, Tanaka T, Ogata T: Two novel and one recurrent PTPN11 mutations in LEOPARD syndrome. Am J Med Genet A 2004;130:432-434. (Pubitemid 39441624)
70. Tartaglia M, Martinelli S, Stella L, Bocchinfuso G, Flex E, et al: Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease. Am J Hum Genet 2006;78:279-290. (Pubitemid 43157567)
71. Yagubyan M, Panneton JM, Lindor NM, Conti E, Sarkozy A, Pizzuti A: LEOPARD syndrome: a new polyaneurism association and an update on the molecular genetics of the disease. J Vasc Surg Apr. 2004;39:897-900. (Pubitemid 38405826)
72. Pacileo G, Calabrò P, Limongelli G, Santoro G, Digilio MC, Sarkozy A, et al: Diffuse coronary artery dilation in a young patient with LEOPARD syndrome. Int J Cardiol 2006;112:e35-e37. (Pubitemid 44353808)
73. Roberts A, Allanson J, Jadico SK, Kavamura MI, Noonan J, et al: The cardiofacio-cutaneous (CFC) syndrome: a review. J Med Genet 2006;43:833-842.
74. Gripp KW, Lin AE, Nicholson L, Allen W, Cramer A, et al: Further delineation of the phenotype resulting from BRAF or MEK1 germline mutations helps differentiate Cardio-Facio-Cutaneous syndrome from Costello syndrome. Am J Med Genet A 2007;143:1472-1480. (Pubitemid 47051026)
75. Van Eeghen AM, Van Gelderen I, Hennekam R C M: Costello syndrome: Report and review. Am J Med Genet 1999;82:187-193. (Pubitemid 29055075)
76. Lin AE, Gripp KW, Kerr B: Costello syndrome; in Cassidy SB, Allanson JE (eds): Management of Genetic Syndromes, ed. 2, pp 151-161 (John Wiley & Sons, Inc., Hoboken, New Jersey 2005).
77. Gripp KW, Lin AE, Stabley DL, Nicholson L, Scott CI Jr, et al: HRAS mutation analysis in Costello syndrome: Genotype and phenotype correlation. Am J Med Genet A 2006;140:1-7. (Pubitemid 43054028)
78. Digilio MC, Sarkozy A, Capolino R, Chiarini Testa MB, Esposito G, et al: Costello syndrome: clinical diagnosis in the first year of life. Eur J Pediatr 2008;167:621-628. (Pubitemid 351503496)
79. Lin AE, Birch PH, Korf BR, Tenconi R, Niimura M, et al: Cardiovascular malformations and other cardiac abnormalities in neurofibromatosis 1 (NF1). Am J Med Genet 2000;95:108-117.
80. Friedman JM, Arbiser J, Epstein JA, Gutmann DH, Huot SJ, et al: Cardiovascular disease in neurofibromatosis 1: Report of the NF1 Cardiovascular Task Force. Genet Med 2002;4:105-111. (Pubitemid 44698568)
81. De Luca A, Bottillo I, Sarkozy A, Carta C, Neri C, et al: NF1 gene mutations represent the major molecular event underlying Neurofibromatosis- Noonan syndrome. Am J Hum Genet 2005;77:1092-1101. (Pubitemid 41698528)
82. Venturin M, Guarnieri P, Natacci F, Stabile M, Tenconi R, et al: Mental retardation and cardiovascular malformations in NF1 microdeleted patients point to candidate genes in 17q11.2. J Med Genet 2004;41:35-41. (Pubitemid 38125685)
83. Brannan CI, Perkins AS, Vogel KS, Ratner N, Nordlund ML, et al: Targeted disruption of the Neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. Genes Dev 1994;8:1019-1029. (Pubitemid 24145666)
84. Hamilton SJ, Friedman JM: Insights into the pathogenesis of neurofibromatosis 1 vasculopathy. Clin Genet 2000;58:341-344.